Diseases & Conditions market research reports by DelveInsight

• T cell Lymphoma -Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  T cell Lymphoma -Pipeline Insight, 2023 DelveInsight’s, “T-cell Lymphoma -Pipeline Insight, 2023” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

• Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023 DelveInsight’s, “Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the pipeline d ... Read More

• Fibromyalgia- Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Fibromyalgia- Pipeline Insight, 2023 DelveInsight’s, “Fibromyalgia- Pipeline Insight, 2023” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Fibromyalgia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More

• Asthma - Market Insight, Epidemiology and Market Forecast -2032

  Jun 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Asthma - Market Insight, Epidemiology and Market Forecast -2032 DelveInsight's ""Asthma- Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, ... Read More

• Chemotherapy-induced peripheral neuropathy - Epidemiology Forecast - 2032

  Jun 01, 2023  |  Published by: DelveInsight  |  USD 3,950

  Chemotherapy-induced peripheral neuropathy - Epidemiology Forecast - 2032 Key Highlights Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent, dose-dependent complication of anticancer drugs, including platinum, taxanes, epothilones, vinca alkaloids, and newer agents, such as bortezomib. ... Read More

• Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032

  Jun 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032 Key Highlights: In Japan, the contribution of KRAS mutations is lower compared to Western countries like the United States and Europe In the United States, KRASG12C is present in ~ ... Read More

• Triple Negative Breast Cancer - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Triple Negative Breast Cancer - Pipeline Insight, 2023 DelveInsight’s, “Triple Negative Breast Cancer - Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles ... Read More

• Anal Cancer - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 1,250

  Anal Cancer - Pipeline Insight, 2023 DelveInsight’s, “Anal Cancer - Pipeline Insight, 2023” report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Anal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More

• Asthma- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Asthma- Pipeline Insight, 2023 DelveInsight’s, “Asthma- Pipeline Insight, 2023,” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Asthma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• Postoperative Pain- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  Postoperative Pain- Pipeline Insight, 2023 DelveInsight’s, “Postoperative Pain- Pipeline Insight, 2023,” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Postoperative Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica ... Read More

• Sjogren’s syndrome- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Sjogren’s syndrome- Pipeline Insight, 2023 DelveInsight’s, “Sjogren’s syndrome- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Sjogren’s syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Ovarian Cancer- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Ovarian Cancer- Pipeline Insight, 2023 DelveInsight’s, “Ovarian Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More

• Hepatitis C Virus Infection- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Hepatitis C Virus Infection- Pipeline Insight, 2023 DelveInsight’s, “Hepatitis C Virus Infection- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hepatitis C Virus Infection pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

• Metastatic Uveal Melanoma - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Metastatic Uveal Melanoma - Pipeline Insight, 2023 DelveInsight’s, “Metastatic Uveal Melanoma - Pipeline Insight, 2023,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Metastatic Uveal Melanoma pipeline landscape. It covers the pipeline drug profiles, including ... Read More

• Axial spondyloarthritis (axSpA) - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Axial spondyloarthritis (axSpA) - Pipeline Insight, 2023 DelveInsight’s, “Axial spondyloarthritis (axSpA) - Pipeline Insight, 2023” report provides comprehensive insights about 15+companies and 15+pipeline drugs in Axial spondyloarthritis (axSpA) pipeline landscape. It covers the pipeline drug profi ... Read More

• Graves Ophthalmopathy - Epidemiology Forecast - 2032

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,950

  Graves Ophthalmopathy - Epidemiology Forecast - 2032 Key Highlights Graves’ Ophthalmopathy represents a broad spectrum of disease; although the diagnosis is readily apparent in those with severe and active disease, establishing the diagnosis in patients with lesser degrees of Graves’ Ophthalmopathy ... Read More

• COVID-19- Competitive Landscape, 2023

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  COVID-19- Competitive Landscape, 2023 DelveInsight’s, “COVID-19 - Competitive landscape, 2023,” report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mol ... Read More

• Asthma- Competitive landscape, 2023

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,500

  Asthma- Competitive landscape, 2023 DelveInsight’s, “Asthma- Competitive landscape, 2023,” report provides comprehensive insights about 110+ companies and 125+ drugs in Asthma Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule t ... Read More

• Sleep Aid- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Sleep Aid- Market Insights, Competitive Landscape, and Market Forecast - 2027 Sleep Aids Market By Product Type (Pharmaceuticals [Prescription, Over The Counter (OTC), Herbal And Dietary Supplements], Sleep Aid Devices), By Application (Insomnia, Obstructive Sleep Apnea (OSA), Narcolepsy And Others) ... Read More

• Treatment-resistant Depression - Epidemiology Forecast - 2032

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,950

  Treatment-resistant Depression - Epidemiology Forecast - 2032 DelveInsight’s ‘Treatment Resistant Depression (TRD) Overview - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Treatment Resistant Depression (TRD), historical and forecasted epidemiology as well as the Treat ... Read More

• Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027 Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to adva ... Read More

• Chemotherapy Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Chemotherapy Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2027 Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer ... Read More

• Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023 DelveInsight’s, “Angioimmunoblastic T cell Lymphoma – Pipeline Insight, 2023,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Angioimmunoblastic T cell Lymphoma pipeline landscape. It covers the pipelin ... Read More

• Ocular Hypertension- Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Ocular Hypertension- Pipeline Insight, 2023 DelveInsight’s, “Ocular Hypertension- Pipeline Insight, 2023” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... Read More

• HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023 DelveInsight’s, “HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2 Negative Breast Cancer pipeline landscape. It cov ... Read More

< prev 16 17 18 19 20 21 22 23 24 25 next >